Related Experiment Video
Updated: Aug 11, 2026

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
Published on: June 16, 2011
Ribavirin's antiviral mechanism of action: lethal mutagenesis?
Shane Crotty1, Craig Cameron, Raul Andino
1Department of Microbiology and Immunology, University of California, San Francisco, CA 94143, USA. crotty@microbio.emory.edu
Abstract:
Ribavirin, an antiviral drug discovered in 1972, is interesting and important for three reasons: (a) it exhibits antiviral activity against a broad range of RNA viruses; (b) it is currently used clinically to treat hepatitis C virus infections, respiratory syncytial virus infections, and Lassa fever virus infections; and (c) ribavirin's mechanism of action has remained unclear for many years. Here we recount the history of ribavirin and review recent reports regarding ribavirin's mechanism of action, including our studies demonstrating that ribavirin is an RNA virus mutagen and ribavirin's primary antiviral mechanism of action against a model RNA virus is via lethal mutagenesis of the RNA virus genomes. Implications for the development of improved versions of ribavirin and for the development of novel antiviral drugs are discussed.
Related Concept Videos
In-vitro Mutagenesis
Viral Mutations
Mechanisms of Retrovirus-induced Cancers
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors

